HomeInsightsMarket Capitalization

Market Capitalization of Aarti Drugs Ltd

Market Capitalization of Aarti Drugs Ltd

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

15.0 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

MARKETCAP

₹ 4555.38 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Aarti Drugs Ltd is ₹ 4555 crore as of 07 Nov 24.
  • The Market Cap of Aarti Drugs Ltd changed from ₹ 1510 crore on March 2019 to ₹ 3988 crore on March 2024 . This represents a CAGR of 17.57% over 6 years. .
  • The Latest Trading Price of Aarti Drugs Ltd is ₹ 495.5 as of 07 Nov 15:30.
  • The Dividend Payouts of Aarti Drugs Ltd changed from ₹ 1 on Jul 26, 2019 to ₹ 1 on Feb 06, 2024 . This represents a CAGR of 0.00% over 6 years. .

Historical Market Cap of Aarti Drugs Ltd

No data available

* All values are in crore

Company Fundamentals for Aarti Drugs Ltd

No data available

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

PRICE

₹ 495.5

1.20 (0.24%)

stock direction

Last updated on: Nov 07 03:30 PM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024495.5
06 Nov 2024494.3
05 Nov 2024487.95
04 Nov 2024483.55
01 Nov 2024487.6
31 Oct 2024483.6
30 Oct 2024485.05
29 Oct 2024484.15
28 Oct 2024483.15
25 Oct 2024475.05

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Aarti Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Aarti Drugs Ltd

No data available

No data available

Historical P/E Ratio of Aarti Drugs Ltd

No data available

* All values are in %

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Aarti Drugs Ltd

No data available

* All values are in

About Aarti Drugs Ltd

  • Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
  • The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
  • With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
  • It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
  • It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

Aarti Drugs Ltd News Hub

News

Aarti Drugs to conduct board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 24 October 202...

Read more

18 Oct 202410:48

News

Aarti Drugs gains after arm receives UK MHRA GMP Compliance Certificate

The company said that there are no financial or material impacts as of now. With the GMP c...

Read more

04 Oct 202411:09

News

Aarti Drugs' Maharashtra facility gets 7 observations from USFDA

The API inspection was conducted from 12 September to 20 September 2024. At the conclusion...

Read more

21 Sep 202414:05

News

Aarti Drugs extends buyback offer period

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday...

Read more

16 Sep 202408:52

News

Aarti Drugs AGM scheduled

Aarti Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

03 Sep 202411:38

News

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up ...

Read more

26 Aug 202417:17

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Aarti Drugs Ltd Market Cap

What is the market cap of Aarti Drugs Ltd?

As of November 8, 2024, Aarti Drugs Ltd has a market capitalization of ₹4555.38, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Aarti Drugs Ltd's market capitalization?

Aarti Drugs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Aarti Drugs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Aarti Drugs Ltd's market capitalization change?

Aarti Drugs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*